• Respiratory Drugs, Budesonide
    Dosage form: Inhaler
    Strength: 90mcg, 180mcg
    Indications/Special comments: Prophylaxis of asthma.
    Dosage Administration: Inhaler: 180mcg twice daily, may be reduced in well-controlled asthma to not less than 180mcg daily; in severe asthma dose may be increased to 1.44mg daily; Child: 40 – 360mcg twice daily, in severe asthma may be increased to 720mcg daily.
    View full drug info
  • Respiratory Drugs, Bromhexine Hydrochloride
    Dosage form: Tablet
    Strength: 8mg
    Indications/Special comments: Common cold, influenza, infections of the respiratory tract or in other conditions where excess mucus is produced.
    Dosage Administration: Adults: One tablet (8 mg) three times a day. May be increased to two tablets (16mg) three times a day for the first seven days. Children 6 – 11 years: 1 tablet three times a day. Note: Do not use in children under 6 years of age.
    View full drug info
  • Respiratory Drugs, Bromhexine Hydrochloride
    Dosage form: Elixir
    Strength: 0.8mg/ml, 1.6mg.ml
    Indications/Special comments: Common cold, influenza, infections of the respiratory tract or in other conditions where excess mucus is produced.
    Dosage Administration: Adults: 5ml (8mg) three times a day. May be increased to 10ml (16mg) three times a day for the first seven days. Children 6 - 11 years: 5ml (8mg) three times a day.
    View full drug info
  • Respiratory Drugs, Beclomethasone Dipropionate
    Dosage form: Inhaler
    Strength: 50mcg/dose (MDI)
    Indications/Special comments: Chronic persistent asthma.
    Dosage Administration: Adult: 200 micrograms twice daily or 100 micrograms three or four times daily. Severe cases 600 – 800 micrograms daily; Child: 50 – 100 micrograms two to four times daily. Note: Gargling and rinsing the mouth with water after each dose is recommended to help prevent hoarseness, throat irritation, and oral candidiasis. The use of a spacing device may also greatly decrease the incidence of these local adverse effects.
    View full drug info
  • Preparations used for diluting and dissolving parental preparations, Bacteriostatic Saline
    Dosage form: Injection
    Strength: 0.009
    Indications/Special comments: Indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.
    Dosage Administration: The volume of the preparation to be used for diluting or dissolving any drug for injection is dependent on the vehicle concentration, dose and route of administration as recommended by the manufacturer.
    View full drug info
  • Ophthalmics - Antiallergies, diagnostics and miscellaneous agents, Balanced Salts Plus Solution
    Dosage form: Eye Drop
    Strength: 30 ml, 500ml
    Indications/Special comments: Extraocular and intraocular irrigating solution during ocular surgical procedure involving perfusion of the eye with an expected maximum duration of less than 60 minutes.
    Dosage Administration: Should be used according to standard format for each surgical procedure.
    View full drug info
  • Ophthalmics - Antiallergies, diagnostics and miscellaneous agents, Balanced Salt Solution
    Dosage form: Eye Drop
    Strength: 18ml, 500ml
    Indications/Special comments: Extraocular and intraocular irrigating solution during ocular surgical procedure involving perfusion of the eye with an expected maximum duration of less than 60 minutes.
    Dosage Administration: Should be used according to standard format for each surgical procedure.
    View full drug info
  • Obstetric and Gynaecological Medications, Bupivacaine
    Dosage form: Injection
    Strength: 0.25%, 0.5%, 0.75% (preservative free)
    Indications/Special comments: Long-acting local anaesthetic agent administered as epidural injection. Particularly useful for producing prolonged analgesia during labour, where the interval between doses is usually 2 - 3 hours.
    Dosage Administration: Adult: Dosage depends on site of injection, procedure used, and the status of the patient: Not more than 2mg/kg (with or without adrenaline) should be administered in any 4 hour period, and in 24 hours the total amount should not exceed 400mg. Child: Local infiltration: 2mg/kg. Regional anaesthesia: 2.5mg/kg.
    View full drug info
  • Obstetric and Gynaecological Medications, Bromocriptine Mesylate
    Dosage form: Tablet
    Strength: 2.5mg, 5mg
    Indications/Special comments: Galactorrhoea, amenorrhoea and infertility associated with hyperprolactinaemia, and certain cases of acromegaly (adjunctive therapy). It is used to suppress lactation after stillbirth or abortion, or when breast-feeding is contraindicated.
    Dosage Administration: Adult: Suppression of lactation: 2.5mg twice daily for 2 weeks, starting not before 4 hours after parturition, and provided that viral signs have established. If lactation recurs 2 - 3 days after treatment is stopped, it may be reinstituted and continued for another week. Hypogonadism or amenorrhoeal, galactorrhoea syndromes: Initially 1.25mg once daily at bedtime; gradually increases to an average of 2.5mg 2 - 3 times daily.
    View full drug info
  • Obstetric and Gynaecological Medications, Beractant
    Dosage form: Injection
    Strength: 25mg/ml
    Indications/Special comments: Prevention and treatment of respiratory distress syndrome (RDS) in premature infants. Prophylactic therapy: Body weight <1250 g in infants at risk for developing, or with evidence of, surfactant deficiency (administer within 15 minutes of birth). Rescue therapy: Treatment of infants with RDS confirmed by x-ray and requiring mechanical ventilation (administer as soon as possible - within 8 hours of age).
    Dosage Administration: Endotracheal: Premature infants: Prophylactic treatment: Administer 4mL/kg (100mg phospholipids/kg) as soon as possible; as many as 4 doses may be administered during the first 48 hours of life, no more frequently than 6 hours apart. The need for additional doses is determined by evidence of continuing respiratory distress; if the infant is still intubated and requiring at least 30% inspired oxygen to maintain a PaO2 =80 torr. Rescue treatment: Administer 4mL/kg (100mg phospholipids/kg) as soon as the diagnosis of RDS is made; may repeat if needed, no more frequently than every 6 hours to a maximum of 4 doses. See product literature for special notes on administration.
    View full drug info